As extractables and leachables studies become increasingly important across pharmaceutical and medical device development, keeping pace with evolving regulatory expectations is essential. Increased scrutiny from authorities including the FDA and MHRA means organisations need robust E&L strategies to minimise risk, support compliance and avoid costly delays.

For almost two decades, Smithers’ E&L conference series has brought together experts from across Europe, the USA and China to share the latest developments in regulation, analytical methods and industry best practice.

Attend E&L Europe to:

• Understand the latest regulatory expectations and guidance
• Learn practical approaches to extractables and leachables testing
• Hear real-world case studies and technical insights
• Network with pharmaceutical manufacturers, CROs, packaging specialists and analytical experts
• Benchmark your strategies against industry peers
• Identify solutions to reduce risk and accelerate development timelines

Whether you work in pharmaceuticals, packaging, analytical services, research or manufacturing, E&L Europe offers technical content and networking opportunities designed to support every stage of product development.

Key topics for 2026 include:

• AI and digital transformation in E&L
• Advanced analytical chemistry and extractables identification
• Toxicological risk assessment and safety strategies
• Single-use systems and industry harmonisation
• Medical devices and combination products
• Real-world E&L implementation and case studies.